KALA BIO, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by KALA BIO, Inc. on September 16, 2025. The filing announces the establishment of the date for the Company's 2025 Annual Meeting of Stockholders and provides deadlines for shareholder proposals and director nominations.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
The primary material change reported is the scheduling of the 2025 Annual Meeting for December 11, 2025. This date represents a shift of more than 30 calendar days from the anniversary of the 2024 annual meeting, necessitating specific deadlines for shareholder communications.
Guidance, Outlook, and Corporate Actions
- Annual Meeting Date: The Board of Directors set December 11, 2025, as the date for the 2025 Annual Meeting.
- Rule 14a-8 Proposals: Stockholder proposals for inclusion in proxy materials must be received by October 1, 2025.
- Director Nominations: Due to the meeting date being delayed by more than 60 days from the prior anniversary, notices for director nominations or other matters under the By-Laws must be received by September 28, 2025.
- Future Communications: Details regarding the exact time, location, and matters to be voted on will be published in the proxy statement.
Key Facts for Investor Verification
- Verify the receipt deadline for Rule 14a-8 proposals is October 1, 2025.
- Confirm the deadline for director nominations under the By-Laws is September 28, 2025.
- Note that the 2025 Annual Meeting is scheduled for December 11, 2025.
- Monitor future filings for the proxy statement containing voting matters and meeting logistics.